A detailed history of Paloma Partners Management CO transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Paloma Partners Management CO holds 14,802 shares of JAZZ stock, worth $1.64 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
14,802
Holding current value
$1.64 Million
% of portfolio
0.05%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$103.94 - $118.98 $1.54 Million - $1.76 Million
14,802 New
14,802 $1.58 Million
Q2 2021

Aug 16, 2021

SELL
$160.2 - $186.42 $952,709 - $1.11 Million
-5,947 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$150.19 - $173.5 $893,179 - $1.03 Million
5,947 New
5,947 $978,000
Q3 2020

Nov 16, 2020

SELL
$105.46 - $144.13 $1.39 Million - $1.91 Million
-13,227 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$95.68 - $121.88 $1.27 Million - $1.61 Million
13,227 New
13,227 $1.46 Million
Q4 2019

Feb 14, 2020

SELL
$117.65 - $153.73 $598,720 - $782,331
-5,089 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$125.18 - $143.24 $1.68 Million - $1.92 Million
-13,421 Reduced 72.51%
5,089 $652,000
Q2 2019

Aug 14, 2019

BUY
$125.55 - $144.48 $2.32 Million - $2.67 Million
18,510 New
18,510 $2.64 Million
Q1 2019

May 15, 2019

SELL
$121.81 - $142.95 $1.1 Million - $1.29 Million
-9,000 Closed
0 $0
Q4 2018

Feb 14, 2019

BUY
$115.94 - $166.74 $888,911 - $1.28 Million
7,667 Added 575.17%
9,000 $1.12 Million
Q3 2018

Nov 14, 2018

BUY
$161.01 - $180.57 $214,626 - $240,699
1,333 New
1,333 $224,000
Q2 2018

Aug 14, 2018

SELL
$146.33 - $183.18 $508,057 - $636,000
-3,472 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$135.59 - $157.16 $489,615 - $567,504
-3,611 Reduced 50.98%
3,472 $525,000
Q4 2017

Feb 14, 2018

BUY
$131.06 - $150.39 $928,297 - $1.07 Million
7,083
7,083 $954,000

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $6.95B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.